Mackenzie Financial Portfolio holdings
AUM
$77.2B
1-Year Return
22.51%
This Quarter Return
+0.48%
1 Year Return
+22.51%
3 Year Return
+61.14%
5 Year Return
+128.52%
10 Year Return
+216.87%
AUM
$67.3B
AUM Growth
-$1.82B
(-2.6%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
22.59%
Holding
1,665
New
146
Increased
574
Reduced
657
Closed
131
Top Buys
| 1 |
Exxon Mobil
XOM
|
$185M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$178M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$174M |
| 4 |
Apple
AAPL
|
$161M |
| 5 |
Shopify
SHOP
|
$139M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$240M |
| 2 |
Aon
AON
|
$159M |
| 3 |
Bank of Montreal
BMO
|
$145M |
| 4 |
Copart
CPRT
|
$125M |
| 5 |
Honeywell
HON
|
$122M |
Sector Composition
| 1 | Technology | 21.44% |
| 2 | Financials | 20.78% |
| 3 | Industrials | 12.2% |
| 4 | Healthcare | 9.16% |
| 5 | Energy | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
E.W. Scripps
SSP
$261M
| $63.5K | ﹤0.01% |
+20,238
| New | +$63.5K |
|
|
DHC
1477
Diversified Healthcare Trust
DHC
$995M
| $63.2K | ﹤0.01% |
20,726
-7,970
| -28% | -$24.3K |
|
1478
Vanda Pharmaceuticals
VNDA
$272M
| $61.8K | ﹤0.01% |
10,937
-4,027
| -27% | -$22.8K |
|
1479
Compass
COMP
$5.07B
| $60.9K | ﹤0.01% |
16,915
| – | – |
|
|
EGRX
1480
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $60.4K | ﹤0.01% |
+10,786
| New | +$60.4K |
|
|
ETWO
1481
DELISTED
E2open Parent Holdings
ETWO
| $58.5K | ﹤0.01% |
13,022
| – | – |
|
1482
Information Services Group
III
$253M
| $58.1K | ﹤0.01% |
19,760
| – | – |
|
1483
Pitney Bowes
PBI
$2.11B
| $57.6K | ﹤0.01% |
11,341
| – | – |
|
1484
Emerald Holding
EEX
$1.02B
| $57K | ﹤0.01% |
10,026
-5,746
| -36% | -$32.7K |
|
|
PGRE
1485
Paramount Group
PGRE
$1.66B
| $56.7K | ﹤0.01% |
12,251
| – | – |
|
1486
TrueCar
TRUE
$191M
| $56.6K | ﹤0.01% |
18,076
-25,325
| -58% | -$79.3K |
|
|
SVC
1487
Service Properties Trust
SVC
$481M
| $54.5K | ﹤0.01% |
10,611
-636
| -6% | -$3.27K |
|
1488
Nektar Therapeutics
NKTR
$764M
| $54.3K | ﹤0.01% |
2,918
-3,551
| -55% | -$66K |
|
1489
Sabre
SABR
$675M
| $53.4K | ﹤0.01% |
20,001
| – | – |
|
|
PSTX
1490
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $51.4K | ﹤0.01% |
+17,616
| New | +$51.4K |
|
|
BDN
1491
Brandywine Realty Trust
BDN
$759M
| $49.8K | ﹤0.01% |
11,106
| – | – |
|
1492
Aldeyra Therapeutics
ALDX
$334M
| $49.7K | ﹤0.01% |
15,024
-493
| -3% | -$1.63K |
|
1493
Globalstar
GSAT
$3.96B
| $49.6K | ﹤0.01% |
2,951
| – | – |
|
1494
Lantronix
LTRX
$185M
| $49.6K | ﹤0.01% |
+13,965
| New | +$49.6K |
|
1495
iHeartMedia
IHRT
$315M
| $49.6K | ﹤0.01% |
45,475
| – | – |
|
1496
Aurora
AUR
$10.6B
| $49.4K | ﹤0.01% |
17,849
-1,247
| -7% | -$3.45K |
|
1497
Nordic American Tanker
NAT
$692M
| $49.3K | ﹤0.01% |
12,394
| – | – |
|
1498
Leslie's
LESL
$64.6M
| $47.1K | ﹤0.01% |
11,251
| – | – |
|
1499
FibroGen
FGEN
$48.9M
| $43.6K | ﹤0.01% |
1,953
+941
| +93% | +$21K |
|
1500
Spero Therapeutics
SPRO
$121M
| $42.5K | ﹤0.01% |
32,729
+4,287
| +15% | +$5.57K |
|